Therapeutic ligands are molecules designed to bind to specific targets in cancer cells. These can be small molecules, antibodies, or peptides. They work by either activating or inhibiting specific pathways. For example, monoclonal antibodies like trastuzumab target HER2 receptors in breast cancer, while small molecule inhibitors like gefitinib target EGFR in lung cancer.
